CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for IBN SINA Pharmaceutical Industry Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

IBN SINA Pharmaceutical Industry Ltd
Tanin Center
3 Asad Gate, Mirpur Road, Mohammadpur
Phone: +880 241022150p:+880 241022150 DHAKA, 1207  Bangladesh Ticker: IBNSINAIBNSINA
Business Summary
The IBN SINA Pharmaceutical Industry Ltd is a Bangladesh-based pharmaceutical company. The Company is engaged in production, trading, and other related activities of Active Pharmaceutical Ingredients (API) and other related products. The Company offers its products under pharma and natural. Its products in a range of therapeutic class, such as Antibiotic, Anti-ulcerant, Antiasthmatic, Antihistamine, Cough Medicines, Antidiabetic, Antispasmodic, Antineuropathic, Cardiovascular drugs (CVS drugs), Central Nervous System (CNS drugs), Gastroprokinetic agent, NSAIDs (nonsteroidal anti-inflammatory drugs) and Laxative. In Antibiotics the Company is enriched in Penicillins with brands Sinamox, Sinaclox, Sinaflox, among others. In Anti-ulcerant portfolio having pioneer brands like Dexlan and Gavisol. Antiasthmatic drugs including Ventisal, Ventisal-L, Xofyl, Montex, among others. Antihistamine brands including Bilamin, Fexomin, Rupamin, Ebamin, Sinamin, Nosemin, Silora, among others.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/20246/30/2024Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations

General Information
Outstanding Shares: 31,243,627 (As of 6/30/2024)
Shareholders: 11,634
Stock Exchange: DSE
Fax Number: +880 241022140


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 20, 2024